About this trial
Ovarian cancer remains the deadliest gynecologic malignancy, with poor survival rates largely due to late-stage diagnosis. Early detection is crucial, yet no universally accepted screening method exists. Current imaging techniques and biomarkers, such as CA-125, have limitations in specificity and sensitivity. This study aims to develop and evaluate a deep learning-based computer-aided diagnosis tool (CAT-OV), for ovarian cancer detection using CT imaging. The system integrates a Body Part Regression (BPR) model for pelvic localization and a Multiple Instance Learning (MIL) ensemble classifier for cancer prediction. The model was trained and validated using retrospective datasets from Taiwan, the United States, and a nationwide real-world cohort. Stringent preprocessing and quality control measures were implemented to enhance model accuracy. Results highlight the potential of AI-driven CT screening in improving early detection, though further validation is needed for clinical adoption.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Age ≥ 20 years old.
Female
undergone a CT scan
undergone a CT scan within 180 days prior to ovarian surgery for histopathological evaluation.
Disqualifiers
Age < 20 years old.
Non-female
Non-CT imaging
Incorrect image orientation
Trial population
Women who have undergone a CT scan.
Trial design
Case-control
Retrospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Performance of a deep learning-based computer-aided diagnosis tool (CAT-OV) for identification of primary ovarian cancer on CT
Sensitivity, Specificity, Accuracy, PPV, NPV, AUC
Sponsors and contacts
Click on the lead sponsor to view all of their trials.